Status: current, Defined. Date: 31-Dec 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 4766651000168112 | riltozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module | 
| 4766661000168114 | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | Is a | tozinameran + riltozinameran | true | Inferred relationship | Some | ||
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has Australian BoSS | tozinameran | true | Inferred relationship | Some | 342807358 | |
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has intended active ingredient | tozinameran | true | Inferred relationship | Some | 342807358 | |
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has unit of use | vial | true | Inferred relationship | Some | 811677667 | |
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has Australian BoSS | riltozinameran | true | Inferred relationship | Some | 1007658402 | |
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | has intended active ingredient | riltozinameran | true | Inferred relationship | Some | 1007658402 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Comirnaty Original/Omicron BA.1 Multidose injection, 2.25 mL vial | Is a | True | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | |
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 195 x 2.25 mL vials | has MPUU | True | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | 1097813516 | 
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 10 x 2.25 mL vials | has MPUU | True | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | 1738625870 | 
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set